Noninvasive detection of bilirubin using pulsatile absorption. by McEwen, Mark & Reynolds, Karen Jane
Archived at the Flinders Academic Commons 
http://dspace.flinders.edu.au/dspace/ 
This is the author's postprint version of this article.  
The original can be found at: http://www.acpsem.org.au/journal/index_journal.html 
 
NONINVASIVE DETECTION OF BILIRUBIN 
USING PULSATILE ABSORPTION 
 
Mark McEwen1, 2, Karen Reynolds1 
1School of Informatics and Engineering, Flinders University 
2Flinders Biomedical Engineering, Flinders Medical Centre 
Adelaide 5042, Australia 
Mark.McEwen@flinders.edu.au 
 
ABSTRACT 
Bilirubin, the yellow substance usually responsible for 
neonatal jaundice, is currently monitored invasively or by 
observing/measuring skin colour.  This paper investigates 
the feasibility of monitoring serum bilirubin concentration 
using light absorbance in a similar fashion to pulse 
oximetry.  The light absorbance of bilirubin is shown to 
be sufficiently different to haemoglobin to in theory allow 
direct noninvasive serum bilirubin monitoring using light 
absorbance around 480nm. 
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1. Introduction 
Oxygenated and reduced haemoglobin are major 
absorbers of visible and near infrared light in blood.  This 
strong light absorbance is exploited in pulse oximetry 
where the ratio of oxygenated to total haemoglobin is 
determined, based on the ratio of light absorbance at 2 
different wavelengths. 
Theoretically, the Beer Lambert law states: 
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If base-10 logarithms are used, equation 2 becomes: 
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Pulse oximetry is carried out by measuring the absorbance 
of light either shining through tissue (eg fingertip or 
earlobe) or reflected from/within tissue.  With these 
configurations light passes through several layers of tissue 
and blood, and encounters several light absorbing and 
scattering substances. 
 
Figure 1: Simple model of light scattered, absorbed 
and transmitted through tissue - as occurs in pulse 
oximetry 
However, as can be seen in figure 1, the conditions of the 
Beer-Lambert law are not satisfied in pulse oximetry: 
Tissue is not a non-scattering pure light absorbing 
solution.  The mean distance between light scattering 
events encountered by a photon travelling through tissue 
has been estimated at between 50 and 200µm [1].  Due to 
this multiple scattering, light travelling through tissue 
becomes effectively isotropic within a short distance of 
entering tissue [2].        
The pathlength of light through blood (within tissue) and 
the intensities of light entering and leaving blood (within 
tissue) are unknown. 
These problems are overcome in pulse oximetry by 
analysing only the pulsatile component of light 
absorbance (figure 2), quoting results as a percentage – 
allowing simplification of equation 3, and by empirical 
calibration. 
The volume of arterial blood between light source and 
detector pulsates with the cardiac cycle; therefore the light 
pathlength through blood will pulsate, and the amount of 
light absorbing substance (mostly haemoglobin) will also 
pulsate. 
 
Figure 2: Photodetector output when 940nm light was 
shone through an adult finger onto the photodetector, 
showing the pulsatile and non pulsatile components 
Providing light propagation changes due to in vivo 
rouleaux formation are negligible throughout the cardiac 
cycle, the maximum and minimum light intensities 
striking the detector correspond to the intensities of light 
entering and leaving the pulsatile volume of haemoglobin 
solution respectively (Ii and Io in equations 1 & 2) 
By measuring the ratio of absorbance of light at 
wavelengths where oxyhaemoglobin and reduced 
haemoglobin have different absorption coefficients, the 
ratio of oxygenated to total haemoglobin can be 
determined. 
Pulse oximetry assumes that there are only 2 major 
absorbers of red and near infrared light in blood.  This 
assumption is not quite correct, as haemoglobin can exist 
as carboxyhaemoglobin or methaemoglobin, as well as 
oxyhaemoglobin and reduced haemoglobin [1], although 
carboxyhaemoglobin and methaemoglobin are not usually 
present in high concentrations. 
Apart from haemoglobins, there is another major light 
absorber that is sometimes present in blood – bilirubin.  
Bilirubin is a non-polar molecule [3, 4] with a distinct 
yellow colour, which is a by-product of haemoglobin 
breakdown. 
Most newborn babies (approximately 60%) experience 
hyperbilirubinemia, which is classified as a serum 
bilirubin concentration above 86µM (5mg/dL) [4].  Serum 
bilirubin concentration has traditionally been determined 
from blood samples obtained via a “heel-stick” procedure, 
which involves pain and infection risk as well as delays 
associated with laboratory tests remote to the patient. 
A method for monitoring serum bilirubin noninvasively is 
available; Transcutaneous Bilirubinometry (TcB) involves 
measuring the skin reflectance of various colours of light 
(wavelengths) to assess the “yellowness” of the skin [5], 
which is correlated to the serum bilirubin concentration.  
TcB has sometimes been reported to be an accurate 
screening method for hyperbilirubinemia [6] although 
some papers identify significant errors between TcB 
readings and laboratory serum bilirubin tests [5].  The 
accuracy of TcB is reported to be lower in dark skinned 
babies than in light skinned babies, and the accuracy 
reportedly drops during phototherapy and blood 
transfusions [7]. 
Because bilirubin exists in blood and is a strong absorber 
of light (figure 3) there is the possibility that it could be 
monitored in a similar fashion to pulse oximetry.  Such a 
method would be independent of skin melanin 
concentration, phototherapy and blood transfusions. 
2. Method 
Published absorption spectra were collected for 
haemoglobin (Hb), oxyhaemoglobin (HbO), 
carboxyhaemoglobin (cHb), methaemoglobin (metHb) 
and bilirubin (figures 3 & 4). 
 
Figure 3: Absorption spectra for Haemoglobins, & 
Bilirubin in the 400-650nm range [2, 8-13] 
 
 
Figure 4: Absorption spectra for Haemoglobins, & 
Bilirubin in the 650-1000nm range [2, 8-13] 
Figures 3 & 4 represent absorption coefficients for use 
with natural logarithms (equation 2), not base-10 
logarithms (equation 4). 
Concentrations were assigned to these analytes as follows: 
Total haemoglobin: 15g/dL 
Oxyhaemoglobin: 97.5% of total haemoglobin = 
14.625g/dL ≈  2.285mM 
Reduced haemoglobin: 2% of total haemoglobin = 
0.3g/dL ≈  0.047mM 
Bilirubin: 5mg/dL (the lower limit for 
hyperbilirubinemia) ≈  0.086mM 
Methaemoglobin: 0.25% of total haemoglobin = 
37.5mg/dL ≈  0.006mM 
Carboxyhaemoglobin: 0.25% of total haemoglobin = 
37.5mg/dL ≈  0.006mM 
A nominal pulsatile distance (ie the change in light 
pathlength through blood between diastole and systole – d 
in equations 1-4) was calculated using the measured 
photodetector outputs (figure 2) and the graphed 
absorption coefficients (figure 4). 
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The absorbance of light by each species listed above, was 
calculated using the Beer-Lambert law (equation 1), 
eg at 660nm: 
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Therefore the total absorbance at 660nm was 
      8.8+1.83+0.017+0.224  
      = 10.871milli absorbance units 
The percentage absorbances due to the 5 chemical species 
were: 
%0:Bilirubin
%1.2%100
871.10
224.0:metHb
%2.0%100
871.10
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The absorbance due to each species was calculated 
throughout the range 400-1000nm, and area graphs were 
generated, showing the absorbance of each species versus 
wavelength of light. 
Pulse oximeters generally use Light Emitting Diodes 
(LEDs) as sources.  LEDs generate light which spans a 
range of wavelengths, as shown by the LED spectrum in 
figure 5, the bandwidth for this LED at 50% maximum 
intensity being approximately 40nm. 
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 Figure 5: Normalised spectrum recorded from a LED 
with centre wavelength of 520nm 
An instrument that monitors serum bilirubin 
concentration, using a similar method to pulse oximetry, 
may use LEDs as light sources.  To see the effect of using 
LEDs as light sources, two sets of absorption graphs were 
produced – one showing the absorption of light with a 
bandwidth of 1nm in wavelength, the other showing the 
absorbance of light from a 40nm wide band of 
wavelengths.  The latter graphs were produced by 
averaging the absorption coefficients for the chemical 
species shown in figures 3 & 4, over 40nm. 
3. Results 
The contributions of bilirubin and the 4 haemoglobin 
species to the absorption of light, with 1nm bandwidth, 
are shown in figures 6 & 7. 
 
Figure 6: Absorbance in the 400-550nm range due to 
Bilirubin & haemoglobin species, with light bandwidth 
= 1nm 
 
 
Figure 7: Absorbance in the 550-1000nm range due to 
Bilirubin & haemoglobin species, with light bandwidth 
= 1nm 
The contribution of bilirubin and the 4 haemoglobin 
species to the absorption of light, with 40nm bandwidth, 
is shown in figures 8 & 9. 
 Figure 8: Absorbance in the 400-550nm range due to 
Bilirubin & haemoglobin species, with light bandwidth 
= 40nm 
 
 
Figure 9: Absorbance in the 550-1000nm range due to 
Bilirubin & haemoglobin species, with light bandwidth 
= 40nm 
With 97.5% oxygen saturation of haemoglobin and 
5mg/dL serum bilirubin concentration: 
At 660nm, reduced haemoglobin accounts for 16.8% of 
absorbance of 1nm bandwidth light, and 15.8% of 40nm 
bandwidth light. 
At 804nm, reduced haemoglobin accounts for 1.9% of 
absorbance of 1nm bandwidth light, and 2.1% of 40nm 
bandwidth light. 
At 940nm, reduced haemoglobin accounts for 1.2% of 
absorbance of both 1nm and 40nm bandwidth light. 
At 480nm, bilirubin accounts for 3.9% of absorbance of 
1nm bandwidth light and 3.7% of 40nm bandwidth light. 
4. Discussion 
Comparing the contributions made by bilirubin and 
reduced haemoglobin, to the absorption signals enables 
the difficulty in measuring bilirubin concentration to be 
compared to the difficulty in performing pulse oximetry.  
660nm is an important wavelength in pulse oximetry; 
approximately 15.8% of light absorbance at this 
wavelength is due to reduced haemoglobin, while only 
3.7% of light absorbance at 480nm is due to bilirubin.  
Therefore bilirubin’s contribution to the overall 
absorbance signal at 480nm is only about one quarter of 
the contribution of reduced haemoglobin to the 
absorbance signal at 660nm.  This means that the task of 
noninvasively measuring bilirubin using light absorbance 
could be around 4 times more difficult than pulse 
oximetry, but given the advances in technology since 
pulse oximetry was first introduced it should still be 
possible. 
The absorbance area graphs show: 
There is much higher overall absorbance around 480nm 
(where bilirubin may more easily be detected) than in the 
660 to 940 nm region (where pulse oximetry is 
performed); so much higher power light sources would be 
required for bilirubin detection than for pulse oximetry. 
As the bandwidth of light from the source becomes 
narrow, the percentage absorbance due to bilirubin at 
480nm increases only slightly, indicating that there is no 
real advantage in using narrow bandwidth light sources in 
this instance.  This suggests that LEDs are suitable light 
sources to be used in noninvasive serum bilirubin 
monitoring. 
There are areas attributable to methaemoglobin 
absorbance, in figures 6-9 around 640nm and 900nm – 
indicating that the presence of methaemoglobin can 
render pulse oximetry and the proposed bilirubin 
detection method inaccurate if it is not compensated for. 
The absorbance due to carboxyhaemoglobin (at 
0.3mg/dL) was not large enough to be easily seen in 
figures 6-9. 
Quantifying results from noninvasive light absorbance 
measurement is perhaps the most difficult obstacle to 
overcome – due to the difficulties in determining an 
effective pathlength through the pulsatile component of 
blood.  Pulse oximetry avoids this problem by quoting 
results as a percentage, allowing pathlength to be 
cancelled from calculations.  It may be possible to 
perform a similar calculation – bilirubin concentration 
could be calculated as a percentage of total haemoglobin 
concentration.  Otherwise there is the possibility of 
calibrating an instrument on each patient against blood 
sample laboratory tests, then subsequent tests can all be 
done noninvasively. 
The effect of other light absorbing substances in blood 
(apart from the 4 haemoglobin species and bilirubin) has 
not been taken into account in this analysis. 
5. Conclusion 
This analysis shows that serum bilirubin in theory should 
be able to be monitored directly and noninvasively in a 
similar fashion to pulse oximetry, providing that high 
power light sources are used, and all potential 
confounding light absorbing substances, eg 
methaemoglobin, are also measured and included in 
calculations.  Ideally, an instrument measuring bilirubin 
concentration using this means would be similar to a pulse 
oximeter but with additional capability.  Results could be 
quoted as a percentage of haemoglobin concentration, 
alternatively absolute concentrations could be determined 
if an instrument is calibrated on each patient against an 
initial laboratory serum bilirubin test. 
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